Literature DB >> 18985334

Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.

Armando Luis Negri1, Francisco Rodolfo Spivacow, Elisa Elena Del Valle, Mariano Forrester, Gabriela Rosende, Irene Pinduli.   

Abstract

In recent decades there has been an increasing prevalence of urolitithiasis in many western countries and at the same time there has been an increasing progression of obesity that has reached epidemic proportions. The aim of the present study was to assess the influence of overweight/obesity on the metabolic risk factors for renal stone formation. We studied 799 renal stone formers (462 men and 337 women) who came to the clinic for metabolic risk factors evaluation. They were all studied with a standard protocol (two 24-h urine collections and serum parameters). They were divided according to their BMI in normal (BMI < 25) overweight (BMI 25-29.9) and obese (BMI > 30). Low-weight individuals were excluded. Overall, 487 of 799 (60.9%) patients had a BMI > 25, including 40.6% overweight and 20.3% obese. Among women 55.2% had normal weight, 25.5 were overweight, and 19.3% were Obese; among men 27.3% had normal weight, 51.7 were overweight, and 21% were obese. Age increased significantly with increasing BMI both in men and women. In women there was a significant increase in the excretion of oxalate, uric acid, phosphorus, creatinine, and sodium with increasing BMI, but no change was observed in calcium, magnesium, citrate, and urine pH. In men there was a significant increase in the excretion of oxalate, uric acid, creatinine, phosphorus, sodium, magnesium, and citrate with increasing BMI, no change in urinary calcium and significant progressive decrease in urinary pH. In this population of stone formers there was a high prevalence of overweight/obesity (60.9%). Both in men and women we found a significant increase in the urinary excretion of two promoters of stone formation, oxalate, and uric acid but no change in urinary calcium. There was either no change or increase in magnesium and citrate, inhibitors of crystallization, and a significant decrease in urine pH only in men.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18985334     DOI: 10.1007/s00240-008-0161-5

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  16 in total

Review 1.  The pathogenesis and treatment of kidney stones.

Authors:  F L Coe; J H Parks; J R Asplin
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

2.  [Obesity as one of the risk factors for urolithiasis].

Authors:  S Nishio; M Yokoyama; H Iwata; M Takeuchi; O Kamei; T Sugamoto; Y Seike; K Ochi; M Kin; K Aoki; S Nabeshima; H Takeda; S Takei
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1998-06

3.  Time trends in reported prevalence of kidney stones in the United States: 1976-1994.

Authors:  Kiriaki K Stamatelou; Mildred E Francis; Camille A Jones; Leroy M Nyberg; Gary C Curhan
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

4.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

5.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

6.  Obesity, weight gain, and the risk of kidney stones.

Authors:  Eric N Taylor; Meir J Stampfer; Gary C Curhan
Journal:  JAMA       Date:  2005-01-26       Impact factor: 56.272

7.  Body size and 24-hour urine composition.

Authors:  Eric N Taylor; Gary C Curhan
Journal:  Am J Kidney Dis       Date:  2006-12       Impact factor: 8.860

8.  Association of urinary pH with body weight in nephrolithiasis.

Authors:  Naim M Maalouf; Khashayar Sakhaee; Joan H Parks; Frederic L Coe; Beverley Adams-Huet; Charles Y C Pak
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

9.  Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.

Authors:  Wesley O Ekeruo; Yeh Hong Tan; Matthew D Young; Philipp Dahm; Michaella E Maloney; Barbara J Mathias; David M Albala; Glenn M Preminger
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

10.  The role of overweight and obesity in calcium oxalate stone formation.

Authors:  Roswitha Siener; Sara Glatz; Claudia Nicolay; Albrecht Hesse
Journal:  Obes Res       Date:  2004-01
View more
  23 in total

1.  Body fat content and distribution and urinary risk factors for nephrolithiasis.

Authors:  Federica Pigna; Khashayar Sakhaee; Beverley Adams-Huet; Naim M Maalouf
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 8.237

Review 2.  Urinary stone disease and obesity: Different pathologies sharing common biochemical mechanisms.

Authors:  Ozgu Aydogdu
Journal:  World J Nephrol       Date:  2012-02-06

3.  Obesity and urolithiasis: evidence of regional influences.

Authors:  Alberto Trinchieri; Emanuele Croppi; Emanuele Montanari
Journal:  Urolithiasis       Date:  2016-08-03       Impact factor: 3.436

Review 4.  Stone formation and management after bariatric surgery.

Authors:  Sarah Tarplin; Vishnu Ganesan; Manoj Monga
Journal:  Nat Rev Urol       Date:  2015-04-07       Impact factor: 14.432

5.  The impact of body mass index on quantitative 24-h urine chemistries in stone forming patients: a systematic review and meta-analysis.

Authors:  Qing Wang; Weijie Hu; Yuchao Lu; Henglong Hu; Jiaqiao Zhang; Shaogang Wang
Journal:  Urolithiasis       Date:  2018-02-08       Impact factor: 3.436

6.  Metabolic diagnosis in stone formers in relation to body mass index.

Authors:  Elisa Elena Del Valle; Armando Luis Negri; Francisco Rodolfo Spivacow; Gabriela Rosende; Mariano Forrester; Irene Pinduli
Journal:  Urol Res       Date:  2011-06-10

7.  Difference in urinary stone components between obese and non-obese patients.

Authors:  Yii-Her Chou; Ching-Ming Su; Ching-Chia Li; Chia-Chu Liu; Mu-En Liu; Wen-Jeng Wu; Yung-Shun Juan
Journal:  Urol Res       Date:  2010-12-16

Review 8.  Current medical treatment in pediatric urolithiasis.

Authors:  Yiğit Akın; Murat Uçar; Selçuk Yücel
Journal:  Turk J Urol       Date:  2013-12

9.  Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.

Authors:  Naim M Maalouf; Prasanthi Tondapu; Eve S Guth; Edward H Livingston; Khashayar Sakhaee
Journal:  J Urol       Date:  2010-01-21       Impact factor: 7.450

Review 10.  Treatment of patients with uric acid stones.

Authors:  Ita Pfeferman Heilberg
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.